Approval · Notice of Compliance 170 · 2004
ANDRIOL: Notice of Compliance 170
Issued March 18, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 170
- Date
- March 18, 2004
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in formulation with improved stability at ambient conditions
- Therapeutic class
- Androgen
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDRIOL | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE UNDECANOATE 40 MG per CAP